A Cost Utility Analysis of Interdisciplinary Early Intervention Versus Treatment as Usual For High-Risk Acute Low Back Pain Patients

Pain Practice

Volumn 10, Issue 5, 2010, Pages 382-395

  Rogerson, Mark D ^a   Gatchel, Robert J ^b   Bierner, Samuel M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Cost effectiveness; Early intervention; Low back pain; QALY; Quality adjusted life years

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENTEEISM; ADULT; AGED; ARTICLE; CHRONIC PAIN; COGNITIVE THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; EARLY INTERVENTION; EMPLOYMENT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; PHYSIOTHERAPY; QUALITY ADJUSTED LIFE YEAR; TRAVEL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 78149473284     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2009.00344.x     Document Type: Article

References (41)

1. Turk DC, Monarch ES. Biopsychosocial approaches on chronic pain. In: Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner's Handbook. New York: Guilford Press; 2002:3-29.
2. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain. 1998;77:231-239.
3. American Academy of Pain Management. Proceedings of The 2003 Annual Meeting of the American Chronic Pain Association. Denver, Co; 2003.
4. Crombie IK, Croft PR, Linton SJ, Leresche L, Von Korff M. Epidemiology of Pain. Seattle, WA: IASP Press; 1999.
5. United States Bureau of the Census. Statistical Abstract of the United States. Washington, DC: United States Bureau of the Census; 1996.
6. National Resource Council. Musculoskeletal Disorders and the Workplace. Washington, DC: National Academy Press; 2001.
7. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a world health organization study in primary care. J Am Med Assoc. 1998;280:147-151.
8. Marketdata Enterprises.Chronic Pain Management Programs: A Market Analysis. New York: Valley Stream; 1995.
9. Mayer TG, Gatchel RJ. Functional Restoration for Spinal Disorders: The Sports Medicine Approach. Philadelphia, PA: Lea & Febiger; 1988.
10. Gatchel RJ. Clinical Essentials of Pain Management. Washington, DC: American Psychological Association; 2005.
11. Turk DC, Flor H. Chronic pain: a biobehavioral perspective. In: Gatchel RJ, Turk DC, eds. Psychosocial Factors in Pain: Critical Perspectives. New York: Guilford Press; 1999:18-34.
12. Gatchel RJ, Turk DC. Interdisciplinary treatment of chronic pain patients. In: Gatchel RJ, Turk DC, eds. Psychosocial Factors In Pain: Critical Perspectives. New York: The Guilford Press; 1999.
13. Gardea MA, Gatchel RJ. Interdisciplinary treatment of chronic pain. Curr Rev Pain. 2000;4:18-23.
14. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain. 1992;49:221-230.
15. Gatchel RJ, Okifuji A. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain. 2006;7:779-793.
16. Gatchel RJ, Polatin PB, Mayer TG. The dominant role of psychosocial risk factors in the development of chronic low-back pain disability. Spine. 1995;20:2702-2709.
17. Schultz IZ, Crook JM, Berkowitz J, et al. Biopsychosocial multivariate predictive model of occupational low back disability. Spine. 2002;27:2720-2725.
18. Gatchel RJ, Polatin PB, Noe C, et al. Treatment- and cost-effectiveness of early intervention for acute low-back pain patients: a one-year prospective study. J Occup Rehabil. 2003;13:1-9.
19. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
20. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. J Am Med Assoc. 1996;276:1253-1258.
21. Haddix AC, Shaffer PA. Cost-effectiveness analysis. In: Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press; 1996:103-129.
22. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.
23. Hatten AL, Gatchel RJ, Polatin PB, Stowell AW. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years. Clin J Pain. 2006;22:700-711.
24. Rivero-Arias O, Campbell H, Gray A, et al. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. Br Med J. 2005;330:1239.
25. Whitehurst DGT, Lewis M, Yao GL, et al. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial. Arthritis Rheum. 2007;57:466-473.
26. Davis JB. Medical Fees In The United States. Los Angeles: Practice Management Information Corporation; 2008.
27. Red Book: Pharmacy's Fundamental Reference. 110th ed. Montvale, NJ: Thomson Healthcare; 2008.
28. Million R, Hall R, Nilsen KH, Baker RD. Assessment of the progress of the back-pain patient. Spine. 1982;7:204-212.
29. Hazard RG, Fenwick JW, Kalisch SM, et al. Functional restoration with behavioral support: a one-year prospective study of patients with chronic low back pain. Spine. 1989;14:157-161.
30. Ware JE, Snow KK, Kosinski M, Gandeck B. SF-36 Health Survey: Manual And Interpretive Guide. Boston, MA: The Health Institute; New England Medical Center; 1993.
31. Ware JE, Kosinski M, Keller SD. SF-36 Physical And Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
32. Pickard AS, Wang Z, Walton SM, Lee TA. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes. 2005;3:11.
33. Wood M. Statistical inference using bootstrap confidence intervals. Significance. 2004;1:180-182.
34. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res. 2002;11:455-468.
35. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry. 2005;184:106-108.
36. Center for the Evaluation of Value and Risk in Health. The Cost Effectiveness Analysis Registry: Institute for Clinical Research & Health Policy Studies. Tufts Medical Center. Available at: (accessed July 10, 2009).
37. Whitfill T. Early Intervention Options For Acute Low Back Pain PatIENTS: A Prospective One-Year Follow-Up Study. Dallas, TX: The University Of Texas-Southwestern Medical Center; 2009.
38. Siddiqui O, Ali MW. A comparison of the random-effects pattern mixture model with Last-Observation-Carried-Forward (LOCF) analysis in longitudinal clinical trials with dropouts. J Biopharm Stat. 1998;8:545-563.
39. Stiger TR, Kosinski AS, Barnhart HX, Kleinbaum DG. ANOVA for repeated ordinal data with small sample size? A comparison of ANOVA, MANOVA, WLs and GEE methods by simulation. Commun Stat Simul Comput. 1998;27:357-375.
40. Lord FM. On the statistical treatment of football numbers. Am Psychol. 1953;8:750-751.
41. Brauer CA, Rosen AB, Olchanski NV, Neumann PJ. Cost-utility analyses in orthopedic surgery. J Bone Joint Surg. 2005;87:1253-1259.